New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM Therapeutics to continue development of IgE therapeutic antibody portfolio and novel IgE-based platform technology London, November 30th, 2018 –...
November 30, 2018 - Press Releases